“Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free years later in a small early-stage trial, researchers reported in Nature.

These were patients ‘where you know the risk of the cancer coming back is very high,’ said Dr. Toni Choueiri of Dana-Farber Cancer Institute in Boston, who helped lead the study. ‘And after a median follow up of almost four years, none of the nine vaccinated patients has experienced a recurrence from their kidney cancer.’

…

Working with Merck, the researchers are now testing a similar kidney cancer vaccine in a randomized trial with 272 patients.”

From Reuters.